Board Structure and Firm Performance: Evidence from Listed Pharmaceutical and Biotechnology Firms in Taiwan
碩士 === 逢甲大學 === 經營管理碩士在職專班 === 101 === In this thesis, I attempt to examine the linkage between board structure and firm performance in listed pharmaceutical and biotechnology firms in Taiwan. In particular, I suspect that board size, CEO duality, and the percentage of independent directors on the b...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/88112592578228898343 |
id |
ndltd-TW-101FCU05457024 |
---|---|
record_format |
oai_dc |
spelling |
ndltd-TW-101FCU054570242015-10-13T22:57:02Z http://ndltd.ncl.edu.tw/handle/88112592578228898343 Board Structure and Firm Performance: Evidence from Listed Pharmaceutical and Biotechnology Firms in Taiwan 董事會結構與公司績效之相關性研究-以臺灣之生技醫療類上市櫃公司為例 Chen Chia Chang 陳家章 碩士 逢甲大學 經營管理碩士在職專班 101 In this thesis, I attempt to examine the linkage between board structure and firm performance in listed pharmaceutical and biotechnology firms in Taiwan. In particular, I suspect that board size, CEO duality, and the percentage of independent directors on the board play an important role to affect the function of the board and therefore firm performance. With a sample of 338 firm-year observations between 2002 and 2007, my empirical results indicate that the percentage of independent directors on the board is positively correlated with firm performance. However, the relationship between firm performance and board size as well as CEO duality in contrary is inconsistent as alternative measures or subsamples are applied. While pharmaceutical and biotechnology firms attract investors’ attention recently due to their growing market and revenues, researches on the role of board of directors in this industry remains limited. As the results from this thesis highlight the percentage of independent directors on the board is relatively important compared with other characteristics of board structure, recent act to encourage or force firms to recruit independent directors in several countries, including Taiwan, seems appropriately to reach the goal of protecting shareholder wealth. 潘立芸 2013 學位論文 ; thesis 52 zh-TW |
collection |
NDLTD |
language |
zh-TW |
format |
Others
|
sources |
NDLTD |
description |
碩士 === 逢甲大學 === 經營管理碩士在職專班 === 101 === In this thesis, I attempt to examine the linkage between board structure and firm performance in listed pharmaceutical and biotechnology firms in Taiwan. In particular, I suspect that board size, CEO duality, and the percentage of independent directors on the board play an important role to affect the function of the board and therefore firm performance. With a sample of 338 firm-year observations between 2002 and 2007, my empirical results indicate that the percentage of independent directors on the board is positively correlated with firm performance. However, the relationship between firm performance and board size as well as CEO duality in contrary is inconsistent as alternative measures or subsamples are applied. While pharmaceutical and biotechnology firms attract investors’ attention recently due to their growing market and revenues, researches on the role of board of directors in this industry remains limited. As the results from this thesis highlight the percentage of independent directors on the board is relatively important compared with other characteristics of board structure, recent act to encourage or force firms to recruit independent directors in several countries, including Taiwan, seems appropriately to reach the goal of protecting shareholder wealth.
|
author2 |
潘立芸 |
author_facet |
潘立芸 Chen Chia Chang 陳家章 |
author |
Chen Chia Chang 陳家章 |
spellingShingle |
Chen Chia Chang 陳家章 Board Structure and Firm Performance: Evidence from Listed Pharmaceutical and Biotechnology Firms in Taiwan |
author_sort |
Chen Chia Chang |
title |
Board Structure and Firm Performance: Evidence from Listed Pharmaceutical and Biotechnology Firms in Taiwan |
title_short |
Board Structure and Firm Performance: Evidence from Listed Pharmaceutical and Biotechnology Firms in Taiwan |
title_full |
Board Structure and Firm Performance: Evidence from Listed Pharmaceutical and Biotechnology Firms in Taiwan |
title_fullStr |
Board Structure and Firm Performance: Evidence from Listed Pharmaceutical and Biotechnology Firms in Taiwan |
title_full_unstemmed |
Board Structure and Firm Performance: Evidence from Listed Pharmaceutical and Biotechnology Firms in Taiwan |
title_sort |
board structure and firm performance: evidence from listed pharmaceutical and biotechnology firms in taiwan |
publishDate |
2013 |
url |
http://ndltd.ncl.edu.tw/handle/88112592578228898343 |
work_keys_str_mv |
AT chenchiachang boardstructureandfirmperformanceevidencefromlistedpharmaceuticalandbiotechnologyfirmsintaiwan AT chénjiāzhāng boardstructureandfirmperformanceevidencefromlistedpharmaceuticalandbiotechnologyfirmsintaiwan AT chenchiachang dǒngshìhuìjiégòuyǔgōngsījīxiàozhīxiāngguānxìngyánjiūyǐtáiwānzhīshēngjìyīliáolèishàngshìguìgōngsīwèilì AT chénjiāzhāng dǒngshìhuìjiégòuyǔgōngsījīxiàozhīxiāngguānxìngyánjiūyǐtáiwānzhīshēngjìyīliáolèishàngshìguìgōngsīwèilì |
_version_ |
1718082356947976192 |